Literature DB >> 29764503

Bacteriological profile of neonatal sepsis and antibiotic susceptibility pattern of isolates admitted at Kanti Children's Hospital, Kathmandu, Nepal.

Nikita Singh Yadav1, Saroj Sharma2, Dhiraj Kumar Chaudhary3, Prabhat Panthi4, Pankaj Pokhrel4, Anil Shrestha5, Pappu Kumar Mandal6.   

Abstract

OBJECTIVE: Neonatal sepsis is a major cause of morbidity and mortality of newborns (< 1 month of age). Septicemia and drug resistance is a predominant issue for neonatal death in Nepal. This study is intended to find bacteriological profile of neonatal sepsis and antibiotic susceptibility pattern of the isolates from neonates at Kanti Children's Hospital, Kathmandu, Nepal.
RESULTS: Out of 350 suspected cases of neonatal sepsis, 59 (16.9%) cases showed positive blood culture. The prevalent of positive blood culture with different neonatal risk factors (sex, age, birth weight, gestational age, and delivery mode) showed highest positive bacterial growth in male (52.3%); 3 or above 3 days age (71.2%); low birth weight (62.7%); preterm gestational age (31.4%); and caesarean delivery mode (63.3%). Among positive cases, the bacteriological profile was found highest for Staphylococcus aureus (35.6%) followed by Klebsiella pneumoniae (15.3%). The most sensitive and resistive antibiotics among Gram-positive isolates were gentamicin (93%) and ampicillin (78%), respectively. Meropenem and imipenem showed highest 100% effective and cefotaxime was least (28%) sensitive among Gram-negative isolates. This concludes broad ranges of bacteria are associated with neonatal sepsis and revealed variation in antibiotic susceptibility pattern among bacterial isolates.

Entities:  

Keywords:  Antibiotic susceptibility; Bacteriological profile; Neonatal sepsis; Neonates

Mesh:

Substances:

Year:  2018        PMID: 29764503      PMCID: PMC5952417          DOI: 10.1186/s13104-018-3394-6

Source DB:  PubMed          Journal:  BMC Res Notes        ISSN: 1756-0500


Introduction

Neonatal sepsis is a clinical syndrome (sepsis neonatorum) resulting from the pathophysiologic effects of local or systemic infection. It affects newborns below 1 month of age and encompasses systemic infections including meningitis, pneumonia, arthritis, osteomyelitis and urinary tract infections [1, 2]. Neonates are immune-compromised and defend weakly to bacterial infections. The bacterial agents associated with neonatal sepsis are Group B Streptococci, Escherichia coli, Listeria monocytogenes, coagulase-negative Staphylococci (CoNS), Staphylococcus aureus, Enterococci, Klebsiella spp., Enterobacter spp., Pseudomonas spp., Salmonella spp., H. influenzae, Neisseria meningitidis, and Streptococcus pneumoniae [3-5]. In developing countries, unsafe birthing practices have critical role to cause neonatal infections. Globally, the neonatal morbidity and mortality cases have been estimated to 2.5–3 million, annually [6]. Neonatal mortality rate (NMR) distribution disparities can be seen based on socioeconomic, educational and geographical parameters. In Nepal, neonatal mortality has been found due to septicemia and emergence of drug resistant bacteria. According to Nepal Demographic and Health Survey (2011), 85% of total death is accounted to neonatal sepsis which is higher than previous surveys, 70% in 2006 and 69% in 2001 [7]. NMR is higher in rural areas (34 deaths per 1000 live births) than in urban areas (23 deaths per 1000 live births). Currently, emergence of multidrug resistant bacteria imposes challenges in treatment of neonatal sepsis [8, 9]. Therefore, the knowledge of prevalence of local isolates and their antimicrobial sensitivity pattern is of utmost necessary for prompt antimicrobial therapy of neonatal sepsis. This study aims to determine incidence and bacteriological profile of neonatal sepsis in relation to neonatal risk factors (sex, age, birth weight, gestational age, and mode of delivery) along with antibiotic susceptibility pattern of the isolates from neonates admitted in neonatal intensive care unit of Kanti Children’s Hospital, Kathmandu, Nepal.

Main text

This hospital based cross-sectional study was conducted in Microbiology Laboratory of Kanti Children’s Hospital, Kathmandu, Nepal from April to September 2015. Sample size was determined based on prevalence rate of previous study [8]. A total of 350 suspected cases of neonatal sepsis were included in this study. The diagnosis of neonatal sepsis was based on clinical profile, septic screening, and blood culture.

Methodology

The blood samples (1–2 ml) were collected from suspected neonates following standard aseptic techniques and inoculated directly into brain heart infusion (BHI; HiMedia, M210) broth containing blood in a ratio of (1:5). The culture bottles were incubated immediately at 37 °C for 5–7 days and were examined daily for growth and turbidity, hemolysis of red cells, gas bubbles and clot formation of discrete colonies. This helps in the presumptive diagnosis of positive broth culture. After incubation, subcultured from BHI broth was performed on blood agar (BA; HiMedia, M073) and MacConkey agar (MA; HiMedia, M081). The MA plates were incubated aerobically and BA plates were incubated anaerobically using BBL anaerobic jar with a GasPak™ EZ Gas Generating Container (Becton–Dickinson) at 37 °C for 24 h. The pure isolates obtained from subcultured plates were identified by following standard microbiological techniques which include studies of colony morphology, Gram-staining reactions and various biochemical properties (catalase and oxidase tests, slide and tube coagulase tests, SIM, MRVP, citrate, triple sugar iron, urease tests) [9-11]. Antibiotic susceptibility test of isolates was performed by modified Kirby-bauer disk diffusion method according to guidelines of Clinical and Laboratory Standards Institute (CLSI) [12]. The antibiotics used in this study were ampicillin (10 µg), amoxycillin (30 µg), piperacillin (100 µg), amikacin (30 µg), gentamicin (10 µg), azithromycin (30 µg), cefotaxime (30 µg), ceftazidime (30 µg), ciprofloxacin (5 µg), ofloxacin (5 µg), cotrimoxazole (25 µg), erythromycin (15 µg), meropenem (10 µg), and imipenem (10 µg). All the antibiotic discs used for susceptibility test were purchased from Himedia, India. For biochemical tests and antibiotics sensitivity tests, following reference strains were used for quality control: E. coli ATCC 25922; Pseudomonas aeruginosa ATCC 27853; Klebsiella pneumoniae ATCC 700603; Salmonella typhimurium ATCC 14028; and Staphylococcus aureus ATCC25923. All the data were entered in the worksheet of SPSS software version (16.0) and Chi square test was performed. P value was calculated and considered significant only when it was less than or equal to 0.05.

Results

Out of 350 blood samples, 59 samples showed growth of organism and 291 samples did not show any microbial growth. The incidence of neonatal sepsis was 16.9% among 350 blood samples enrolled in this study. Among positive cases, the bacteriological profile showed 27 (46%) were Gram-positive cocci and 32 (54%) were Gram-negative bacilli. The highest bacterial strains isolated were S. aureus (35.6%) followed by K. pneumoniae (15.3%), Acinetobacter spp. (11.9%), Enterobacter spp. (10.2%), CoNS (10.2%), P. aeruginosa (6.8%), E. coli (6.8%), Citrobacter spp. (1.7%), and S. typhi (1.7%) (Fig. 1). The highest prevalence (52.3%) of positive blood culture was found in the male neonates. There was no significant association between gender and blood culture positivity (P > 0.05). In relation to different neonatal risk factors, positive blood culture showed the highest prevalence of bacterial growth in neonatal cases with 3 or above 3 days age (71.2%); low birth weight (62.7%); preterm gestational age (31.4%); and caesarean mode of delivery (63.3%). Statistical analysis showed that there was significant association between neonatal risk and culture positivity among suspected cases (P < 0.05) (Table 1).
Fig. 1

Bacteriological profile of neonatal sepsis from suspected neonates

Table 1

Prevalence of positive blood culture in relation to different neonatal risk factors

S. no.Neonatal risk factorsCulture positive (%)Culture negative (%)p value
1Sex> 0.05
 Male31 (52.3)173 (59.5)
 Female28 (47.4)118 (40.5)
2Age< 0.05
 Below 3 days17 (28.8)35 (12.0)
 3 or above 3 days42 (71.2)256 (88.0)
3Birth weight< 0.05
 Very low birth weight2 (3.9)1 (0.3)
 Low birth wight37 (62.7)50 (17.2)
 Good birth weight20 (33.9)240 (82.5)
4Gestational age< 0.05
 Preterm22 (31.4)48 (68.6)
 Term37 (13.2)243 (86.7)
5Mode of delivery< 0.05
 Normal21 (7.2)269 (92.3)
 Caesarean38 (63.3)22 (36.7)
Bacteriological profile of neonatal sepsis from suspected neonates Prevalence of positive blood culture in relation to different neonatal risk factors The most effective antibiotic against Gram-positive bacteria was found to be gentamicin (93%) followed by amikacin (89%) and ofloxacin (85%). The least effective drugs were erythromycin (52%) and cefotaxime (63%). Ampicillin showed the highest resistivity 78% among Gram-positive and 91% among Gram-negative isolates (Table 2). Gentamicin (90%) and ofloxacin (90%) were the most sensitive and ampicillin (76%) was the most resistive antibiotics against S. aureus. All the CoNS strains were sensitive towards amikacin and gentamicin. Ampicillin and ciprofloxacin showed the highest resistance (83%, each) among CoNS isolates. Among K. pneumoniae isolates, amikacin, gentamicin, meropenem, and imipenem were found to be 100% sensitive; and ampicillin, cefotaxime, and ceftazidime were found to be 100% resistive. Piperacillin was the most effective against all Acinetobacter and P. aeruginosa isolates. Ampicillin was 100% resistant to Acinetobacter strains and amoxycillin and cotrimoxazole was ineffective to all isolates of P. aeruginosa. Meropenem, imipenem, gentamicin, and amikacin were effective antibiotics against all the isolates of Enterobacter. None of the strain of Enterobacter showed sensitive towards amoxycillin. Ofloxacin, gentamicin, and amikacin were 100% susceptible against E. coli, whereas amoxycillin was resistant towards all E. coli isolates. Ceftazidime, amikacin, gentamicin, and ofloxacin were the most sensitive antibiotics against Citrobacter and S. typhi isolates. But, Ampicillin and cotrimoxazole showed 100% resistivity against Citrobacter and S. typhi isolates (Table 2).
Table 2

Antimicrobial susceptibility patterns of bacterial strains isolated from suspected cases of neonatal sepsis

AntibioticsK. pneumonia n = 9 (%)Acinetobacter spp. n = 7 (%)Enterobacter spp. n = 6 (%)P. aeruginosa n = 4 (%)E. coli n = 4 (%)Citrobacter spp. n = 1 (%)S. typhi n = 1 (%)S. aureus n = 21 (%)CoNS n = 6 (%)
Ampicillin00NTNT2 (50)005 (24)1 (17)
Amoxycillin5 (36)2 (29)00001 (100)16 (76)3 (50)
PiperacillinNT7 (100)NT4 (100)NTNTNTNTNT
Amikacin9 (100)4 (57)6 (100)2 (50)4 (100)1 (100)1 (100)18 (86)6 (100)
Gentamicin9 (100)3 (43)6 (100)3 (75)4 (100)1 (100)1 (100)19 (90)6 (100)
AzithromycinNTNTNTNTNTNT1 (100)NTNT
Cefotaxime03 (43)1 (17)2 (50)2 (50)01 (100)12 (57)5 (83)
Ceftazidime01 (14)2 (33)2 (50)2 (50)1 (100)1 (100)NTNT
Ciprofloxacin5 (56)1 (14)1 (17)2 (50)3 (75)01 (100)18 (86)1 (17)
Ofloxacin7 (78)4 (57)5 (83)3 (75)4 (100)1 (100)1 (100)19 (90)4 (67)
Cotrimoxazole1 (11)5 (71)5 (83)03 (75)00NTNT
ErythromycinNTNTNTNTNTNTNT9 (43)5 (83)
Meropenem9 (100)NT6 (100)NTNT1 (100)NTNTNT
Imipenem9 (100)NT6 (100)NTNT1 (100)NTNTNT
Antimicrobial susceptibility patterns of bacterial strains isolated from suspected cases of neonatal sepsis

Discussion

Neonatal bacterial sepsis is a major cause of death in developing countries like Nepal. The emergence of antibiotics resistant bacteria and its dissemination is exacerbated by inappropriate antimicrobial consumption and precarious living condition. The most common organisms associated with neonatal sepsis vary with time of infections and geographical location [8]. Therefore, information on bacteriological profile of neonatal sepsis and effective antimicrobials for its treatment are important to combat with neonatal morbidity and mortality issues. This study found 16.9% of neonates had microbiologically confirmed sepsis. The incidence rate of this study is quite lower compared to previous studies which have reported the incidence rate above 40% [8, 13]. The low incidence rate is due to the fact that this study was conducted in tertiary care hospital where most of the cases were referred from other hospital and clinics. Most of these referred cases had the history of antibiotics therapy prior to referral. The finding of prevalence of positive blood culture in relation to different neonatal risk factors can be useful to determine the preventive measures for neonatal sepsis (Table 1). The higher rate of growth positivity was observed in male compared to female neonates. These finding is in agreement with previous studies [14-16]. The prevalence of positive blood culture was found to be higher in 3 or above 3 days of age (late onset of sepsis) compared to below 3 days of age (early onset of sepsis). Most of the previous studies have shown similar pattern of high prevalence of neonatal sepsis in late onset of sepsis [9, 17]. Prolonged use of invasive ventilator and catheter, failure of early breast feeding, longer use of parenteral nutrition, hospitalization, surgery, cardiovascular diseases, and respiratory infections lead to late onset of sepsis among neonates [18, 19]. Positive blood culture was observed high (62.7%) in low birth weight neonates. The low birth weight is strong neonatal risk factor that leads to cause neonatal sepsis [14]. This study showed highest infection among preterm neonates compared to term neonates. The most predisposing factors of infection in neonates are premature birth and low birth weight. Preterm neonates have 3 to tenfold higher incidence of infections than full term normal birth weight infants [6]. The neonates delivered by caesarean section showed the highest positive blood culture compared to normal deliver. Studies have revealed increased risk of neonatal death delivered by caesarean compared to vaginal delivery [20]. The bacterial profile revealed the highest prevalence of S. aureus followed by K. pneumoniae Acinetobacter spp., Enterobacter spp., CoNS, P. aeruginosa, E. coli, Citrobacter spp., and S. typhi (Fig. 1). These bacterial strains are predominant causative agents which have been identified by several studies [8, 9, 11, 13, 15]. This study has shown the frequency of isolation of Gram-negative bacteria was higher compared to Gram-positive bacteria. The causative organism varies due to geographical area. Neonates have high chance to acquire large proportion of vaginal Gram-negative bacteria [8]. Among the Gram-positive isolates, S. aureus is predominant hospital acquired organism. Furthermore, S. aureus has greater chance of transmission from health care workers and relatives to neonates [21]. Among Gram-negative isolates, K. pneumoniae accounts the highest which causes infection in neonates. This finding was similar with previous studies conducted among neonates [22, 23]. The antibiotic susceptibility pattern of bacterial isolates from blood culture showed the maximum susceptibility towards amikacin, gentamicin, ciprofloxacin, and ofloxacin. However, the isolates showed the higher resistivity pattern towards ampicillin and amoxycillin. The most effective antibiotics against predominant isolates S. aureus and other CoNS isolates were amikacin, gentamicin, ciprofloxacin, and ofloxacin. For K. pneumoniae and other Gram-negative strains, meropenem, imipenem, amikacin, gentamicin, ciprofloxacin, and ofloxacin were drug of choice for treatment of neonatal sepsis. The antibiotic sensitivity test of bacterial strains isolated from this study provides insight for selection of appropriate drugs for further control of neonatal mortality rate. Ampicillin and amoxycillin which have been revealed as ineffective drugs might be due to emergence of antimicrobial genes in bacteria and inappropriate use of antibiotics prior to hospitalization of neonatal cases [8, 13]. In overall, neonatal septicemia is a life threatening emergency and its rapid treatment with antibiotics is essential. The knowledge of the etiological organisms of neonatal sepsis and their antibiotic susceptibility profile is necessary for effective therapeutic intervention. It is therefore important to note that commencement of empirical antibiotic therapy is of essence while awaiting blood culture result. The initial empiric antibiotic use must therefore be a combination of drugs to cover for the prevalent bacterial organisms in that locality.

Conclusions

This study showed the high prevalence of S. aureus as Gram-positive bacteria and K. pneumoniae as Gram-negative bacteria among suspected neonatal cases. Overall isolates showed maximum sensitivity towards aminoglycosides and quinolones whereas minimum sensitivity towards penicillin. In Nepal, emergence of antibiotic resistance among bacterial isolates from neonatal sepsis is a major cause for treatment failure, higher morbidity and mortality. Proper antibiotic guidelines and its effective implementation could be milestone for revolution in the field of antibiotic resistance control. The epidemiology of neonatal sepsis, causative risk factors and antibiotic resistance pattern of pathogens may be used to develop guidelines for management of neonatal sepsis.

Limitations

This study has enrolled neonates which were only admitted to Kanti Children’s Hospital, Nepal. Future research should covered suspected neonates from different part of Nepal to determine overall neonatal prevalence of the country.
  14 in total

1.  Infant and neonatal mortality for primary cesarean and vaginal births to women with "no indicated risk," United States, 1998-2001 birth cohorts.

Authors:  Marian F MacDorman; Eugene Declercq; Fay Menacker; Michael H Malloy
Journal:  Birth       Date:  2006-09       Impact factor: 3.689

Review 2.  Neonatal sepsis: an international perspective.

Authors:  S Vergnano; M Sharland; P Kazembe; C Mwansambo; P T Heath
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-05       Impact factor: 5.747

3.  Defining common infections in children and neonates.

Authors:  Khalid N Haque
Journal:  J Hosp Infect       Date:  2007-06       Impact factor: 3.926

4.  Risk for late-onset blood-culture proven sepsis in very-low-birth weight infants born small for gestational age: a large multicenter study from the German Neonatal Network.

Authors:  Birte Tröger; Wolfgang Göpel; Kirstin Faust; Thilo Müller; Gerhard Jorch; Ursula Felderhoff-Müser; Ludwig Gortner; Friedhelm Heitmann; Thomas Hoehn; Angela Kribs; Reinhard Laux; Claudia Roll; Michael Emeis; Michael Mögel; Jens Siegel; Matthias Vochem; Axel von der Wense; Christian Wieg; Egbert Herting; Christoph Härtel
Journal:  Pediatr Infect Dis J       Date:  2014-03       Impact factor: 2.129

5.  Neonatal sepsis in a tertiary care hospital in South India: bacteriological profile and antibiotic sensitivity pattern.

Authors:  Bambala Puthattayil Zakariya; Vishnu Bhat; Belgode Narasimha Harish; Thirunavukkarasu Arun Babu; Noyal Mariya Joseph
Journal:  Indian J Pediatr       Date:  2010-12-17       Impact factor: 1.967

6.  Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza-Tanzania.

Authors:  Neema Kayange; Erasmus Kamugisha; Damas L Mwizamholya; Seni Jeremiah; Stephen E Mshana
Journal:  BMC Pediatr       Date:  2010-06-04       Impact factor: 2.125

7.  Incidence, clinical characteristics and risk factors for adverse outcome in neonates with late-onset sepsis.

Authors:  Ming-Horng Tsai; Jen-Fu Hsu; Shih-Ming Chu; Reyin Lien; Hsuan-Rong Huang; Ming-Chou Chiang; Ren-Huei Fu; Chiang-Wen Lee; Yhu-Chering Huang
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129

8.  Neonatal sepsis bacterial isolates and antibiotic susceptibility patterns at a NICU in a tertiary care hospital in western Nepal: a retrospective analysis.

Authors:  C K Shaw; P Shaw; A Thapalial
Journal:  Kathmandu Univ Med J (KUMJ)       Date:  2007 Apr-Jun

9.  Antibiotic usage and its sensitivity pattern in the NICU.

Authors:  R Shrestha; J M Shrestha; B Gurung
Journal:  Kathmandu Univ Med J (KUMJ)       Date:  2012 Apr-Jun

10.  Bacterial isolates of early-onset neonatal sepsis and their antibiotic susceptibility pattern between 1998 and 2004: an audit from a center in India.

Authors:  Ramesh Bhat Y; Leslie Edward S Lewis; Vandana K E
Journal:  Ital J Pediatr       Date:  2011-07-11       Impact factor: 2.638

View more
  15 in total

1.  Bacteriological Profile and Outcome of Culture-Positive Neonatal Sepsis in a Special Newborn Care Unit Setting, Odisha.

Authors:  Nirmal K Mohakud; Jyoti P Mishra; Manas K Nayak; Jayanti Mishra; Lingaraj Pradhan; Subhra Snigdha Panda; Manas Ranjan Bahera; Rishabh Pugulia
Journal:  Cureus       Date:  2022-05-31

2.  Amikacin Combined with Fosfomycin for Treatment of Neonatal Sepsis in the Setting of Highly Prevalent Antimicrobial Resistance.

Authors:  Christopher A Darlow; Fernando Docobo-Perez; Nicola Farrington; Adam Johnson; Laura McEntee; Jennifer Unsworth; Ana Jimenez-Valverde; Silke Gastine; Ruwanthi Kolamunnage-Dona; Renata M A de Costa; Sally Ellis; François Franceschi; Joseph F Standing; Mike Sharland; Michael Neely; Laura Piddock; Shampa Das; William Hope
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

3.  Neonatal Sepsis, Antibiotic Susceptibility Pattern, and Treatment Outcomes among Neonates Treated in Two Tertiary Care Hospitals of Yangon, Myanmar from 2017 to 2019.

Authors:  Nan Aye Thida Oo; Jeffrey K Edwards; Prajjwal Pyakurel; Pruthu Thekkur; Thae Maung Maung; Nant San San Aye; Hla Myat Nwe
Journal:  Trop Med Infect Dis       Date:  2021-04-28

Review 4.  Recent advances in Staphylococcus aureus infection: focus on vaccine development.

Authors:  Shamshul Ansari; Rajesh Kumar Jha; Shyam Kumar Mishra; Birendra Raj Tiwari; Ahmed Morad Asaad
Journal:  Infect Drug Resist       Date:  2019-05-13       Impact factor: 4.003

5.  Neonatal sepsis in Iran: A systematic review and meta-analysis on national prevalence and causative pathogens.

Authors:  Zahra Akbarian-Rad; Seyed Mohammad Riahi; Ali Abdollahi; Parisa Sabbagh; Soheil Ebrahimpour; Mostafa Javanian; VeneelaKrishnaRekha Vasigala; Ali Rostami
Journal:  PLoS One       Date:  2020-01-24       Impact factor: 3.240

6.  Treatment outcomes, antibiotic use and its resistance pattern among neonatal sepsis patients attending Bahawal Victoria Hospital, Pakistan.

Authors:  Muhammad Atif; Rabia Zia; Iram Malik; Nafees Ahmad; Sajjad Sarwar
Journal:  PLoS One       Date:  2021-01-13       Impact factor: 3.240

Review 7.  Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.

Authors:  Christopher A Darlow; Renata M A da Costa; Sally Ellis; François Franceschi; Mike Sharland; Laura Piddock; Shampa Das; William Hope
Journal:  Paediatr Drugs       Date:  2021-08-26       Impact factor: 3.022

8.  Epidemiology of neonatal infections in hospitals of Nepal: evidence from a large- scale study.

Authors:  Shyam Sundar Budhathoki; Avinash K Sunny; Pragya Gautam Paudel; Jeevan Thapa; Lila Bahadur Basnet; Sandeepa Karki; Rejina Gurung; Prajwal Paudel; Ashish Kc
Journal:  Arch Public Health       Date:  2020-05-07

9.  Pattern of bacterial profile and antibiotic susceptibility among neonatal sepsis cases at Cairo University Children Hospital.

Authors:  Mohammad N Almohammady; Eman M Eltahlawy; Nashwa M Reda
Journal:  J Taibah Univ Med Sci       Date:  2020-02-04

10.  Gram-negative neonatal sepsis in low- and lower-middle-income countries and WHO empirical antibiotic recommendations: A systematic review and meta-analysis.

Authors:  Sophie C H Wen; Yukiko Ezure; Lauren Rolley; Geoff Spurling; Colleen L Lau; Saba Riaz; David L Paterson; Adam D Irwin
Journal:  PLoS Med       Date:  2021-09-28       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.